Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3053% above fair value
$27.20+1.54 (+6.00%)
Close on Nov 18, 2026Market cap $2.03BP/E –Yield –
Schrodinger gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Schrodinger's gross profit for the twelve months ending Jun 30, 2026 was $147.31M, up 5.9% year over year. For fiscal 2025 it was $142.61M, up 8.0% from the year before. The highest annual figure on record is $142.61M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $142.61M | +8.0% |
| FY2024 | Dec 31, 2024 | $132.08M | -6.1% |
| FY2023 | Dec 31, 2023 | $140.69M | +39.3% |
| FY2022 | Dec 31, 2022 | $101.02M | +54.0% |
| FY2021 | Dec 31, 2021 | $65.62M | +3.4% |
| FY2020 | Dec 31, 2020 | $63.47M | +29.3% |
| FY2019 | Dec 31, 2019 | $49.09M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $32.43M | +24.0% |
| Q1 FY2026 | Mar 31, 2026 | $29.55M | -5.1% |
| Q4 FY2025 | Dec 31, 2025 | $57.29M | -10.7% |
| Q3 FY2025 | Sep 30, 2025 | $28.04M | +58.2% |
| Q2 FY2025 | Jun 30, 2025 | $26.16M | -16.5% |
| Q1 FY2025 | Mar 31, 2025 | $31.12M | +64.8% |
| Q4 FY2024 | Dec 31, 2024 | $64.13M | +11.4% |
| Q3 FY2024 | Sep 30, 2024 | $17.73M | -25.0% |
| Q2 FY2024 | Jun 30, 2024 | $31.34M | +126.9% |
| Q1 FY2024 | Mar 31, 2024 | $18.89M | -58.7% |
| Q4 FY2023 | Dec 31, 2023 | $57.55M | +48.7% |
| Q3 FY2023 | Sep 30, 2023 | $23.64M | +37.4% |
| Q2 FY2023 | Jun 30, 2023 | $13.81M | -19.4% |
| Q1 FY2023 | Mar 31, 2023 | $45.69M | +63.3% |
| Q4 FY2022 | Dec 31, 2022 | $38.70M | +46.8% |
| Q3 FY2022 | Sep 30, 2022 | $17.20M | +54.8% |
| Q2 FY2022 | Jun 30, 2022 | $17.13M | +43.0% |
| Q1 FY2022 | Mar 31, 2022 | $27.98M | +73.1% |
| Q4 FY2021 | Dec 31, 2021 | $26.36M | +38.8% |
| Q3 FY2021 | Sep 30, 2021 | $11.12M | -27.2% |
| Q2 FY2021 | Jun 30, 2021 | $11.98M | -11.8% |
| Q1 FY2021 | Mar 31, 2021 | $16.16M | +3.4% |
| Q4 FY2020 | Dec 31, 2020 | $18.99M | +22.3% |
| Q3 FY2020 | Sep 30, 2020 | $15.27M | +42.6% |
| Q2 FY2020 | Jun 30, 2020 | $13.58M | +37.9% |
| Q1 FY2020 | Mar 31, 2020 | $15.63M | +20.2% |
| Q4 FY2019 | Dec 31, 2019 | $15.53M | – |
| Q3 FY2019 | Sep 30, 2019 | $10.71M | – |
| Q2 FY2019 | Jun 30, 2019 | $9.85M | – |
| Q1 FY2019 | Mar 31, 2019 | $13.00M | – |
See a number that looks wrong?